Table 2 KEGG pathways in co-expression modules

Module 1

Proteasome

3.90E−07

6.10E−05

Module 2

Ribosome

1.80E−41

2.60E−39

Parkinson’s disease

6.20E−10

4.50E−08

Oxidative phosphorylation

8.50E−10

4.10E-08

Huntington’s disease

2.70E−08

9.90E−07

Alzheimer’s disease

1.40E−06

4.00E−05

Module 3

Epithelial cell signaling in Helicobacter pylori infection

1.80E−05

1.80E−03

Lysosome

2.80E−05

1.30E−03

Vibrio cholerae infection

4.30E−05

1.30E−03

Oxidative phosphorylation

1.70E−03

4.00E−02

Module 4

Ribosome

2.80E−11

1.90E−09

Module 5

Type I diabetes mellitus

3.30E−11

2.60E−09

Antigen processing and presentation

4.20E−11

1.60E−09

Viral myocarditis

2.00E−10

5.10E−09

Allograft rejection

3.30E−10

6.50E−09

Graft-versus-host disease

6.70E−10

1.00E−08